Treatment of cystic fibrosis in infants

Affiliations

¹ The Breathing Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: frank.accurso@childrenscolorado.org.

Comment

Frank J Accurso. Lancet Respir Med. 2018 Jul.

. 2018 Jul;6(7):483-484.

doi: 10.1016/S2213-2600(18)30203-0. Epub 2018 Jun 7.

¹ The Breathing Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: frank.accurso@childrenscolorado.org.

No abstract available

Comment on

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study.
Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Tian S, Schneider J, Cunningham S, Davies JC; ARRIVAL study group. Rosenfeld M, et al. Lancet Respir Med. 2018 Jul;6(7):545-553. doi: 10.1016/S2213-2600(18)30202-9. Epub 2018 Jun 7. Lancet Respir Med. 2018. PMID: 29886024 Free PMC article. Clinical Trial.